483 related articles for article (PubMed ID: 8275496)
21. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Franzén P; Ichijo H; Miyazono K
Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
Dong F; Wu HB; Hong J; Rechler MM
J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
[TBL] [Abstract][Full Text] [Related]
23. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
25. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
26. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
27. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
Bordoni R; Fine R; Murray D; Richmond A
J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
30. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
Mooradian DL; Purchio AF; Furcht LT
Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
[TBL] [Abstract][Full Text] [Related]
32. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
Batova A; Danielpour D; Pirisi L; Creek KE
Cell Growth Differ; 1992 Nov; 3(11):763-72. PubMed ID: 1334692
[TBL] [Abstract][Full Text] [Related]
33. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.
Huggett AC; Hampton LL; Ford CP; Wirth PJ; Thorgeirsson SS
Cancer Res; 1990 Dec; 50(23):7468-75. PubMed ID: 2174726
[TBL] [Abstract][Full Text] [Related]
34. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
35. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
Zeinoun Z; Teugels E; De Bleser PJ; Neyns B; Geerts A; De Greve J
Anticancer Res; 1999; 19(1A):413-20. PubMed ID: 10226576
[TBL] [Abstract][Full Text] [Related]
36. Altered regulation of protein disulfide isomerase in cells resistant to the growth-inhibitory effects of transforming growth factor beta 1.
Sipes NJ; Miller DA; Bascom CC; Winkler JK; Matrisian LM; Moses HL
Cell Growth Differ; 1990 May; 1(5):241-6. PubMed ID: 2085467
[TBL] [Abstract][Full Text] [Related]
37. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
38. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
40. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]